-
New contenders, category heavyweights battle for top spot in cough-cold
Last year, Drug Store News projected that GSK Consumer Healthcare’s Flonase allergy franchise would be challenged with the introduction of two new nasal corticosteroids to the market — McNeil Consumer’s Rhinocort and Bayer’s ClariSpray.
(To view the full Cough-Cold Report, click here.)
-
CDC: Flu incidence on the rise, particularly in the Southeast
ATLANTA — The flu is continuing to impact the United States, especially across the Southeast U.S. for the week ended Jan. 21 the Centers for Disease Control and Prevention reported Friday.
The proportion of outpatient visits for influenza-like illness was 3.4%, well above the national baseline of 2.2% and an increase from the week prior ILI report of 3.2%.